This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Jim Cramer Talks Dollar Tree (DLTR), Apple (AAPL), Coach (COH) and Facebook (FB) Stocks

NEW YORK (TheStreet) -- TheStreet's Jim Cramer answers Twitter  (TWTR) questions from the floor of the New York Stock Exchange, and the first one asks where Walmart  (WMT) stands in the wake of Family Dollar's  (FDO) deal with Dollar Tree  (DLTR).

Cramer calls Dollar Tree a "juggernaut" and tells Walmart to look out. The low end, which used to be Walmart's, is now Dollar Tree's and Cramer loves the store. He finds the prices are great and the selections are terrific and he prefers to go there over Walmart.

The next question asks if suppliers such as GT Advanced Technologies  (GTAT) or service providers would benefit when the new iPhone comes out. Cramer responds with Skyworks  (SWKS) and notes Cirrus Logic  (CRUS) has come down, but he does not like to out-think these situations. If investors like Apple  (AAPL) off an iteration, then they should buy the stock.

Must Watch: Walmart, Family Dollar, Coach Top Cramer's Twitter Q&A

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

The next question deals with Coach (COH), which reports earnings after the bell Monday. Cramer calls it "a very troubled institution" and he does not see any relevance there. He thinks there could be a bit of a bounce but says Michael Kors  (KORS) led the handbag business, and he has stayed away from this group ever since TheStreet's Herb Greenberg wrote Kors has been slowing. Therefore, he does not want to touch Coach.

In the biotech space, Cramer notes Celgene  (CELG) came down and he thought the quarter was excellent. He says CEO Bog Hugin was not promotional and this is a stock that goes up on announcements of new drugs. He likes this stock, but he also likes Biogen Idec  (BIIB) secondarily because Tecfidera is a maintenance drug that people do not have to take all their lives.

Cramer says Gilead's  (GILD) problem is new competition and insurers possibly balking, but he still likes the stock. Finally, Cramer says Regeneron  (REGN) must make its anti-cholesterol pill work because Eylea has taken the company as far as it could, but he thinks founder, president and CEO Leonard Schliefer will make it happen.

Lastly, a recent college graduate who has $10,000 in mutual funds and has started a 401k asks Cramer for a stock recommendation, and he does not hesitate to recommend Facebook  (FB). He thinks the stock will earn $3 in 2016 and could climb to $90 with a 30 multiple.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,265.99 +109.14 0.64%
S&P 500 2,011.36 +9.79 0.49%
NASDAQ 4,593.4250 +31.2360 0.68%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs